
Boan Biotech has announced that it has completed subject enrolment for its international multicentre comparative phase 3 clinical trial of …

Boan Biotech has announced that the first patient has been enrolled in its phase 3 trial of its Nivolumab injection …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

